Results 1 to 10 of about 3,130,322 (229)

Use of complex surgical procedures, patterns of tumor spread, and CA-125 predicts a risk of incomplete cytoreduction: A Korean Gynecologic Oncology Group study (KGOG-3022)

Gynecologic Oncology, 2013
We aimed to develop a risk model to predict a risk of suboptimal cytoreduction in primary surgery of ovarian cancer.The clinical records and computed tomography (CT) data of 358 patients with stages II-IV epithelial ovarian cancer were reviewed. Tumor spread patterns identified by principal component analysis, CA-125, and a newly developed surgical ...
Dae Chul Jung, Byoung Gie Kim, Seung-Cheol Kim   +2 more
exaly   +7 more sources

Secondary surgical cytoreduction needs to be assessed taking into account surgical technique, completeness of cytoreduction, and extent of disease

World Journal of Surgical Oncology, 2020
Recent evidence suggested that secondary surgical cytoreduction followed by chemotherapy does not result in longer overall survival in patients with platinum-sensitive recurrent ovarian cancer.
Juan José Segura-Sampedro, Rafael Morales-Soriano, Álvaro Arjona-Sánchez, Pedro Cascales-Campos   +3 more
doaj   +3 more sources

Upper-Abdominal Cytoreduction for Advanced Ovarian Cancer—Therapeutic Rationale, Surgical Anatomy and Techniques of Cytoreduction

Surgical Techniques Development, 2022
Cytoreductive surgery (CRS) is the cornerstone of treating advanced ovarian cancer. Approximately 60–70% of patients with advanced ovarian cancer will have involvement in the upper abdomen or the supracolic compartment of the abdominal cavity. Though the
G. Bhandoria, A. Bhatt, S. Mehta, O. Glehen   +3 more
semanticscholar   +2 more sources

Hybrid surgical approach for advanced ovarian cancer: hybrid approach for robotic and minimal open abdominal cytoreduction technique [PDF]

Obstetrics & Gynecology Science
Objective To assess the feasibility of a hybrid surgical approach combining robotic-assisted pelvic and laparotomic upper abdominal cytoreduction for advanced ovarian cancer.
Jaekyung Bae, Uisuk Kim, Ji Hyun Kim, Myong Cheol Lim   +3 more
doaj   +2 more sources

Recurrence Patterns After Complete Cytoreduction for Advanced Ovarian Cancer: Robotic Versus Open Surgery [PDF]

Current Oncology
Background: Complete cytoreduction remains the primary surgical objective in advanced ovarian cancer and concerns persist that robotic surgery may result in distinct recurrence patterns and worse oncologic outcomes due to technical limitations, such as ...
Yossi Tzur, Yoav Brezinov, Tomer Bar-Noy, Amber Yasmeen, Melica Nourmoussavi Brodeur, Shannon Salvador, Walter H. Gotlieb, Susie Lau   +7 more
doaj   +2 more sources

Can Routine Preoperative Endoscopy and Colonoscopy Be Meaningful for the Surgery and Postoperative Course of Patients with Advanced Ovarian Cancer? A Single-Centre Retrospective Cohort Study [PDF]

Diagnostics
Background/Objectives: Bowel resection is often required for complete cytoreduction in advanced ovarian cancer, and some units perform upper gastrointestinal endoscopy and colonoscopy beforehand.
Göktürk Han Doğan, Göksever Akpınar, Anıl Doğukan Tutal, Ceren Sağlam Purut, Ayşe Berin Acar, Mehmet Gökçü, Serhat Sarıkaya, Yunus Emre Purut   +7 more
doaj   +2 more sources

Robotic assisted cytoreductive surgery, removal of a recurrent disease in the right pericaval lymph node in a patient with ovarian cancer with the robotic Xi platform [PDF]

Obstetrics & Gynecology Science, 2021
Objective The standard approach for recurrent ovarian cancer is laparotomy. In this video, we present a cytoreductive surgery using the robotic Xi platform to remove a 2.7 cm pericaval tumor.
Massoud Shoraka, Hadeer Metwally, Semiramis Carbajal-Mamani, Joel Cardenas-Goicoechea   +3 more
doaj   +1 more source

Neoadjuvant chemotherapy followed by interval debulking surgery versus primary debulking surgery in the advanced epithelial ovarian cancer- a retrospective cohort study [PDF]

Vojnosanitetski Pregled, 2021
Background/Aim. The gold standard in treating the advanced ovarian cancer (AOC) is primary debulking surgery (PDS) followed by platinum-based adjuvant chemotherapy.
Maričić Slobodan, Mandić Aljoša, Dejanović Ninoslav, Kladar Nebojša, Popović Marina, Ivković-Kapicl Tatjana, Gutić Bojana, Kokanov Dunja   +7 more
doaj   +1 more source

Case Report: Multidisciplinary approach for complete resection of primary advanced low-grade serous ovarian carcinoma involving the iliac vessels and paraspinal region [PDF]

Frontiers in Oncology
BackgroundLow-grade serous ovarian carcinoma (LGSC) is characterized by indolent progression and relative resistance to cytotoxic chemotherapy, making complete cytoreduction the key prognostic determinant.
Naoyuki Ida, Shoji Nagao, Atsushi Fujikawa, Yui Tanaka, Momoko Tanioka, Ryoko Imatani, Yoshinori Tani, Hanako Sugihara, Hirofumi Matsuoka, Kazuhiro Okamoto, Junko Haraga, Chikako Ogawa, Keiichiro Nakamura, Hisashi Masuyama   +13 more
doaj   +2 more sources

Cytoreductive prostatectomy may improve oncological outcomes in patients with oligometastatic prostate cancer: An updated systematic review and meta-analysis [PDF]

Investigative and Clinical Urology, 2023
The oncologic outcomes of cytoreductive prostatectomy (CRP) in oligometastatic prostate cancer (OmPCa) are still controversial. Therefore, we conducted a systematic review and meta-analysis on the oncologic outcome of CRP in OmPCa.
Doo Yong Chung, Dong Hyuk Kang , Hae Do Jung, Joo Yong Lee, Do Kyung Kim , Jee Soo Ha, Jinhyung Jeon, Kang Su Cho   +7 more
doaj   +1 more source